Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

CorMedix (CRMD) Cost of Revenue (2016 - 2025)

CorMedix (CRMD) has disclosed Cost of Revenue for 13 consecutive years, with $27.1 million as the latest value for Q4 2025.

  • Quarterly Cost of Revenue rose 1.14% to $27.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.2 million through Dec 2025, up 17.7% year-over-year, with the annual reading at $38.1 million for FY2025, 32.42% up from the prior year.
  • Cost of Revenue hit $27.1 million in Q4 2025 for CorMedix, up from $11.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $27.1 million in Q4 2025 to a low of $332.0 in Q2 2022.
  • Historically, Cost of Revenue has averaged $5.5 million across 5 years, with a median of $2.0 million in 2023.
  • Biggest five-year swings in Cost of Revenue: crashed 99.15% in 2022 and later surged 980637.05% in 2023.
  • Year by year, Cost of Revenue stood at $48007.0 in 2021, then plummeted by 99.15% to $406.0 in 2022, then skyrocketed by 999512.81% to $4.1 million in 2023, then skyrocketed by 560.99% to $26.8 million in 2024, then grew by 1.14% to $27.1 million in 2025.
  • Business Quant data shows Cost of Revenue for CRMD at $27.1 million in Q4 2025, $11.2 million in Q3 2025, and $6.4 million in Q2 2025.